Document:

ctxr_ex41.htm

EXHIBIT 4.1

 

WARRANT AGENT AGREEMENT

 

WARRANT AGENT AGREEMENT (this “Warrant Agreement”) dated as of ______________ (the “Issuance Date”) between Citius Pharmaceuticals, Inc., a company incorporated under the laws of the State of Nevada (the “Company”), and VStock Transfer, LLC (the “Warrant Agent”).

 

WHEREAS, pursuant to the terms of that certain Underwriting Agreement (“Underwriting Agreement”), dated ______________, by and among the Company and Aegis Capital Corp., as representatives of the underwriters set forth therein, the Company is engaged in a public offering (the “Offering”) of up to shares (the “Shares”) of common stock, par value $0.001 per share (the “Common Stock”) of the Company and up to Warrants (the “Warrants”) to purchase shares of Common Stock (the “Warrant Shares”), including Shares and Warrants issuable pursuant to the underwriters over-allotment option;

 

WHEREAS, the Company has filed with the Securities and Exchange Commission (the “Commission”) a Registration Statement, No. 333-217956, on Form S-1 (as the same may be amended from time to time, the “Registration Statement”), for the registration under the Securities Act of 1933, as amended (the “Securities Act”), of the Shares, Warrants and Warrant Shares, and such Registration Statement was declared effective on ;

 

WHEREAS, the Company desires the Warrant Agent to act on behalf of the Company, and the Warrant Agent is willing to so act, in accordance with the terms set forth in this Warrant Agreement in connection with the issuance, registration, transfer, exchange and exercise of the Warrants;

 

WHEREAS, the Company desires to provide for the provisions of the Warrants, the terms upon which they shall be issued and exercised, and the respective rights, limitation of rights, and immunities of the Company, the Warrant Agent, and the holders of the Warrants; and

 

WHEREAS, all acts and things have been done and performed which are necessary to make the Warrants the valid, binding and legal obligations of the Company, and to authorize the execution and delivery of this Warrant Agreement.

 

NOW, THEREFORE, in consideration of the mutual agreements herein contained, the parties hereto agree as follows:

 

1. Appointment of Warrant Agent. The Company hereby appoints the Warrant Agent to act as agent for the Company with respect to the Warrants, and the Warrant Agent hereby accepts such appointment and agrees to perform the same in accordance with the express terms and conditions set forth in this Warrant Agreement (and no implied terms or conditions).

 

	 
	1
	

 
	 

 

2. Warrants.

 

2.1. Form of Warrants. The Warrants shall be registered securities and shall be evidenced by a global certificate (“Global Certificate”) in the form of Exhibit A to this Warrant Agreement, which shall be deposited on behalf of the Company with a custodian for The Depository Trust Company (“DTC”) and registered in the name of Cede & Co., a nominee of DTC. If DTC subsequently ceases to make its book-entry settlement system available for the Warrants, the Company may instruct the Warrant Agent regarding making other arrangements for book-entry settlement. In the event that the Warrants are not eligible for, or it is no longer necessary to have the Warrants available in, book-entry form, the Company may instruct the Warrant Agent to provide written instructions to DTC to deliver to the Warrant Agent for cancellation the Global Certificate, and the Company shall instruct the Warrant Agent to deliver to DTC separate certificates evidencing Warrants (“Definitive Certificates” and, together with the Global Certificate, “Warrant Certificates”) registered as requested through the DTC system.

 

2.2. Issuance and Registration of Warrants.

 

2.2.1. Warrant Register. The Warrant Agent shall maintain books (“Warrant Register”) for the registration of original issuance and the registration of transfer of the Warrants.

 

2.2.2. Issuance of Warrants. Upon the initial issuance of the Warrants, the Warrant Agent shall issue the Global Certificate and deliver the Warrants in the DTC book-entry settlement system in accordance with written instructions delivered to the Warrant Agent by the Company. Ownership of security entitlements in the Warrants shall be shown on, and the transfer of such ownership shall be effected through, records maintained (i) by DTC and (ii) by institutions that have accounts with DTC (each, a “Participant”).

 

2.2.3. Beneficial Owner; Holder. Prior to due presentment for registration of transfer of any Warrant, the Company and the Warrant Agent may deem and treat the person in whose name that Warrant shall be registered on the Warrant Register (the “Holder”) as the absolute owner of such Warrant for purposes of any exercise thereof, and for all other purposes, and neither the Company nor the Warrant Agent shall be affected by any notice to the contrary. Notwithstanding the foregoing, nothing herein shall prevent the Company, the Warrant Agent or any agent of the Company or the Warrant Agent from giving effect to any written certification, proxy or other authorization furnished by DTC governing the exercise of the rights of a holder of a beneficial interest in any Warrant. The rights of beneficial owners in a Warrant evidenced by the Global Certificate shall be exercised by the Holder or a Participant through the DTC system, except to the extent set forth herein or in the Global Certificate.

 

2.2.4. Execution. The Warrant Certificates shall be executed on behalf of the Company by any authorized officer of the Company (an “Authorized Officer”), which need not be the same authorized signatory for all of the Warrant Certificates, either manually or by facsimile signature. The Warrant Certificates shall be countersigned by an authorized signatory of the Warrant Agent, which need not be the same signatory for all of the Warrant Certificates, and no Warrant Certificate shall be valid for any purpose unless so countersigned. In case any Authorized Officer of the Company that signed any of the Warrant Certificates ceases to be an Authorized Officer of the Company before countersignature by the Warrant Agent and issuance and delivery by the Company, such Warrant Certificates, nevertheless, may be countersigned by the Warrant Agent, issued and delivered with the same force and effect as though the person who signed such Warrant Certificates had not ceased to be such officer of the Company; and any Warrant Certificate may be signed on behalf of the Company by any person who, at the actual date of the execution of such Warrant Certificate, shall be an Authorized Officer of the Company authorized to sign such Warrant Certificate, although at the date of the execution of this Warrant Agreement any such person was not such an Authorized Officer.

 

	 
	2
	

 
	 

 

2.2.5. Registration of Transfer. At any time at or prior to the Expiration Date (as defined below), a transfer of any Warrants may be registered and any Warrant Certificate or Warrant Certificates may be split up, combined or exchanged for another Warrant Certificate or Warrant Certificates evidencing the same number of Warrants as the Warrant Certificate or Warrant Certificates surrendered. Any Holder desiring to register the transfer of Warrants or to split up, combine or exchange any Warrant Certificate shall make such request in writing delivered to the Warrant Agent, and shall surrender to the Warrant Agent the Warrant Certificate or Warrant Certificates evidencing the Warrants the transfer of which is to be registered or that is or are to be split up, combined or exchanged and, in the case of registration of transfer, shall provide a signature guarantee. Thereupon, the Warrant Agent shall countersign and deliver to the person entitled thereto a Warrant Certificate or Warrant Certificates, as the case may be, as so requested. The Company and the Warrant Agent may require payment, by the Holder requesting a registration of transfer of Warrants or a split-up, combination or exchange of a Warrant Certificate (but, for purposes of clarity, not upon the exercise of the Warrants and issuance of Warrant Shares to the Holder), of a sum sufficient to cover any tax or governmental charge that may be imposed in connection with such registration of transfer, split-up, combination or exchange, together with reimbursement to the Company and the Warrant Agent of all reasonable expenses incidental thereto.

 

2.2.6. Loss, Theft and Mutilation of Warrant Certificates. Upon receipt by the Company and the Warrant Agent of evidence reasonably satisfactory to them of the loss, theft, destruction or mutilation of a Warrant Certificate, and, in case of loss, theft or destruction, of indemnity or security in customary form and amount, and reimbursement to the Company and the Warrant Agent of all reasonable expenses incidental thereto, and upon surrender to the Warrant Agent and cancellation of the Warrant Certificate if mutilated, the Warrant Agent shall, on behalf of the Company, countersign and deliver a new Warrant Certificate of like tenor to the Holder in lieu of the Warrant Certificate so lost, stolen, destroyed or mutilated. The Warrant Agent may charge the Holder an administrative fee for processing the replacement of lost Warrant Certificates, which shall be charged only once in instances where a single surety bond obtained covers multiple certificates. The Warrant Agent may receive compensation from the surety companies or surety agents for administrative services provided to them.

 

2.2.7. Proxies. The Holder of a Warrant may grant proxies or otherwise authorize any person, including the Participants and beneficial holders that may own interests through the Participants, to take any action that a Holder is entitled to take under this Agreement or the Warrants; provided, however, that at all times that Warrants are evidenced by a Global Certificate, exercise of those Warrants shall be effected on their behalf by Participants through DTC in accordance the procedures administered by DTC.

 

	
	3
	

	

 

3. Terms and Exercise of Warrants.

 

3.1. Exercise Price. Each Warrant shall entitle the Holder, subject to the provisions of the applicable Warrant Certificate and of this Warrant Agreement, to purchase from the Company the number of shares of Common Stock stated therein, at the price of $______ per whole share, subject to the subsequent adjustments provided in Section 4 hereof. The term “Exercise Price” as used in this Warrant Agreement refers to the price per share at which shares of Common Stock may be purchased at the time a Warrant is exercised. 

 

3.2. Duration of Warrants. Warrants may be exercised only during the period (“Exercise Period”) commencing on the Issuance Date and terminating at 5:00 P.M., New York City time (the “close of business”) on [____________][1] (“Expiration Date”). Each Warrant not exercised on or before the Expiration Date shall become void, and all rights thereunder and all rights in respect thereof under this Warrant Agreement shall cease at the close of business on the Expiration Date.

 

3.3. Exercise of Warrants.

 

3.3.1. Exercise and Payment. (a) Subject to the provisions of this Warrant Agreement, a Holder (or a Participant or a designee of a Participant acting on behalf of a Holder) may exercise Warrants by delivering to the Warrant Agent, not later than 5:00 P.M., New York City time, on any business day during the Exercise Period an election to purchase the Warrant Shares underlying the Warrants to be exercised (i) in the form included in Exhibit B to this Warrant Agreement or (ii) via an electronic warrant exercise through the DTC system (each, an “Election to Purchase”). No later than one (1) Trading Day following delivery of an Election to Purchase, the Holder (or a Participant acting on behalf of a Holder in accordance with DTC procedures) shall: (i) (A) surrender the Warrant Certificate evidencing the Warrants to the Warrant Agent at its office designated for such purpose or (B) deliver the Warrants to an account of the Warrant Agent at DTC designated for such purpose in writing by the Warrant Agent to DTC from time to time, and (ii) deliver to the Company the Exercise Price for each Warrant to be exercised, in lawful money of the United States of America by certified or official bank check payable to the Company or bank wire transfer in immediately available funds to:

 

[Wire/payment information for Company]

 

Any person so designated by the Holder (or a Participant or designee of a Participant on behalf of a Holder) to receive Warrant Shares shall be deemed to have become holder of record of such Warrant Shares as of the time that an appropriately completed and duly signed Election to Purchase has been delivered to the Warrant Agent, provided that the Holder (or Participant on behalf of the Holder) makes delivery of the deliverables referenced in the immediately preceding sentence by the date that is one (1) Trading Day after the delivery of the Election to Purchase. If the Holder (or Participant on behalf of the Holder) fails to make delivery of such deliverables on or prior to the Trading Day following delivery of the Election to Purchase, such Election to Purchase shall be void ab initio. 

________

1 5 years after issuance.

 

	
	4
	

	

 

(b) If any of (i) the Warrants, (ii) the Election to Purchase, or (iii) the Exercise Price therefor, is received by the Warrant Agent on any date after 5:00 P.M., New York City time, or on a date that is not a Trading Day, the Warrants with respect thereto will be deemed to have been received and exercised on the Trading Day next succeeding such date. “Business day” means a day other than a Saturday or Sunday on which commercial Banks in New York City are open for the general conduct of banking business. The “Exercise Date” will be the date on which the materials in the foregoing sentence are received by the Warrant Agent (if by 5:00 P.M., New York City time), or the following Trading Day (if after 5:00 P.M., New York City time), regardless of any earlier date written on the materials. If the Warrants are received or deemed to be received after the Expiration Date, the exercise thereof will be null and void and any funds delivered to the Company will be returned to the Holder or Participant, as the case may be, as soon as practicable. In no event will interest accrue on any funds deposited with the Company in respect of an exercise or attempted exercise of Warrants.

 

(c) If less than all the Warrants evidenced by a surrendered Warrant Certificate are exercised, the Warrant Agent shall split up the surrendered Warrant Certificate and return to the Holder a Warrant Certificate evidencing the Warrants that were not exercised at no charge to the Holder.

 

3.3.2. Issuance of Warrant Shares. (a) The Warrant Agent shall, by 11:00 a.m., New York City time, on the Trading Day following the Exercise Date of any Warrant, advise the Company, the transfer agent and registrar for the Company’s Common Stock, in respect of (i) the number of Warrant Shares indicated on the Election to Purchase as issuable upon such exercise with respect to such exercised Warrants, (ii) the instructions of the Holder or Participant, as the case may be, provided to the Warrant Agent with respect to the delivery of the Warrant Shares and the number of Warrants that remain outstanding after such exercise and (iii) such other information as the Company or such transfer agent and registrar shall reasonably request. 

 

(b) The Company shall, by no later than 5:00 P.M., New York City time, on the third Trading Day following the Exercise Date of any Warrant and the clearance of the funds in payment of the Exercise Price (such date and time, the “Delivery Time”), cause its registrar to electronically transmit the Warrant Shares issuable upon that exercise to DTC by crediting the account of DTC or of the Participant, as the case may be, through its Deposit Withdrawal Agent Commission system.

 

3.3.3. Valid Issuance. All Warrant Shares issued by the Company upon the proper exercise of a Warrant in conformity with this Warrant Agreement shall be validly issued, fully paid and non-assessable.

 

3.3.4. No Fractional Exercise. No fractional Warrant Shares will be issued upon the exercise of the Warrant. If, by reason of any adjustment made pursuant to Section 4, a Holder would be entitled, upon the exercise of such Warrant, to receive an amount in cash equal to the fractional amount multiplied by the exercise price or a number of Warrant Shares rounded up to the next whole share.

 

	
	5
	

	

 

3.3.5. No Transfer Taxes. The Company shall not be required to pay any stamp or other tax or governmental charge required to be paid in connection with any transfer involved in the issue of the Warrant Shares upon the exercise of Warrants; and in the event that any such transfer is involved, the Company shall not be required to issue or deliver any Warrant Shares until such tax or other charge shall have been paid or it has been established to the Company’s satisfaction that no such tax or other charge is due.

 

3.3.6. Date of Issuance. The Company will treat an exercising Holder as a beneficial owner of the Warrant Shares as of the Exercise Date, except that, if the Exercise Date is a date when the stock transfer books of the Company are closed, such person shall be deemed to have become the holder of such shares at the open of business on the next succeeding date on which the stock transfer books are open. 

 

3.3.7. Restrictive Legend Events; Cashless Exercise Under Certain Circumstances. (a) The Company shall use it reasonable best efforts to maintain the effectiveness of the Registration Statement and the current status of the prospectus included therein or to file and maintain the effectiveness of another registration statement and another current prospectus covering the Warrants and the Warrant Shares at any time that the Warrants are exercisable. The Company shall provide to the Warrant Agent and each Holder prompt written notice of any time that the Company is unable to deliver the Warrant Shares via DTC transfer or otherwise without restrictive legend because (i) the Commission has issued a stop order with respect to the Registration Statement, (ii) the Commission otherwise has suspended or withdrawn the effectiveness of the Registration Statement, either temporarily or permanently, (iii) the Company has suspended or withdrawn the effectiveness of the Registration Statement, either temporarily or permanently, (iv) the prospectus contained in the Registration Statement is not available for the issuance of the Warrant Shares to the Holder or (v) otherwise (each a “Restrictive Legend Event”). To the extent that the Warrants cannot be exercised as a result of a Restrictive Legend Event or a Restrictive Legend Event occurs after a Holder has exercised Warrants in accordance with the terms of the Warrants but prior to the delivery of the Warrant Shares, the Company shall, at the election of the Holder, which shall be given within five (5) days of receipt of such notice of the Restrictive Legend Event, either (i) rescind the previously submitted Election to Purchase and the Company shall return all consideration paid by registered holder for such shares upon such rescission or (ii) treat the attempted exercise as a cashless exercise as described in paragraph (b) below and refund the cash portion of the exercise price to the Holder. (b) If a Restrictive Legend Event has occurred, the Warrant shall only be exercisable on a cashless basis. Notwithstanding anything herein to the contrary, the Company shall not be required to make any cash payments or net cash settlement to the Holder in lieu of delivery of the Warrant Shares. Upon a “cashless exercise”, the Holder shall be entitled to receive the number of Warrant Shares equal to the quotient obtained by dividing (A-B) (X) by (A), where: 

 

(A) = the VWAP on the Trading Day immediately preceding the Exercise Date; 

 

(B) = the Exercise Price of the Warrant, as adjusted as set forth herein; and 

 

(X) = the number of Warrant Shares that would be issuable upon exercise of the Warrant in accordance with the terms of the Warrant if such exercise were by means of a cash exercise rather than a cashless exercise.

 

	
	6
	

	

 

If the Warrant Shares are issued in such a cashless exercise, the Company acknowledges and agrees that, in accordance with Section 3(a)(9) of the Securities Act, the Warrant Shares shall take on the registered characteristics of the Warrants being exercised and the Company agrees not to take any position contrary thereto. Upon receipt of an Election to Purchase for a cashless exercise, the Warrant Agent will promptly deliver a copy of the Election to Purchase to the Company to confirm the number of Warrant Shares issuable in connection with the cashless exercise. The Company shall calculate and transmit to the Warrant Agent in a written notice, and the Warrant Agent shall have no duty, responsibility or obligation under this section to calculate, the number of Warrant Shares issuable in connection with any cashless exercise. The Warrant Agent shall be entitled to rely conclusively on any such written notice provided by the Company, and the Warrant Agent shall not be liable for any action taken, suffered or omitted to be taken by it in accordance with such written instructions or pursuant to this Warrant Agreement.

 

3.3.8. Disputes. In the case of a dispute as to the determination of the Exercise Price or the arithmetic calculation of the number of Warrant Shares issuable in connection with any exercise, the Company shall promptly deliver to the Holder the number of Warrant Shares that are not disputed.

 

3.3.9. Beneficial Ownership Limitation. A Holder shall not have the right to exercise any Warrants to the extent that after giving effect to the issuance of Warrant Shares after exercise as set forth on the applicable Election to Purchase, such Holder or a person holding through such Holder (together with such Holder’s or person’s Affiliates (as defined in Rule 405 under the Securities Act), and any other persons acting as a group together with that Holder or person or any of that Holder’s or person’s Affiliates), would beneficially own in excess of 4.99% (“Beneficial Ownership Limitation”) of the Company’s Common Stock. For purposes of the foregoing sentence, the number of shares of Common Stock beneficially owned by a person shall include the number of Warrant Shares that would be owned by that person issuable upon exercise of the Warrants with respect to which such determination is being made, but shall exclude the number of shares of Common Stock (a) which would be issuable upon exercise of the remaining, non-exercised Warrants beneficially owned by that person or any of its Affiliates and (b) underlying any other securities of the Company held by such Holder or its Affiliates that are exercisable or convertible into Common Stock and subject to a limitation on conversion or exercise that is analogous to the limitation contained in this Section 3.3.9. Except as set forth in the preceding sentence, for purposes of this Section 3.3.9, beneficial ownership shall be calculated in accordance with Section 13(d) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”) and the rules and regulations promulgated thereunder, it being acknowledged by the Holder that neither the Warrant Agent nor the Company is representing to the Holder that such calculation is in compliance with Section 13(d) of the Exchange Act and the Holder or beneficial owner is solely responsible for any schedules required to be filed in accordance therewith. To the extent that the limitation contained in this Section 3.3.9 applies, the determination of whether a Warrant is exercisable and of the number of Warrants that are exercisable shall be in the sole discretion of the Holder, and the submission of an Election to Purchase shall be deemed to be the Holder’s determination of whether such Warrant is exercisable and of the number of Warrants that are exercisable, and neither the Warrant Agent nor the Company shall have any obligation to verify or confirm the accuracy of such determination and neither of them shall have any liability for any error made by the Holder or any other person. In addition, a determination as to any group status as contemplated above shall be determined in accordance with Section 13(d) of the Exchange Act and the rules and regulations promulgated thereunder. For purposes of this Section 3.3.9, in determining the number of outstanding shares of Common Stock, a Holder or other person may rely on the number of outstanding shares of Common Stock as reflected in (a) the Company’s most recent periodic or annual report filed with the Securities and Exchange Commission, as the case may be, (b) a more recent public announcement by the Company or (c) a more recent written notice by the Company or the Company’s transfer agent setting forth the number of shares of Common Stock outstanding. For any reason at any time, upon the written or oral request of a person that represents that it is or is acting on behalf of a Holder, the Company shall, within two (2) Trading Days, confirm orally or in writing or by e-mail to that person the number of shares of Common Stock then outstanding. Upon delivery of a written notice to the Company, the Holder may from time to time increase or decrease the Beneficial Ownership Limitation to any other percentage not in excess of 9.99% as specified in such notice, provided that any increase in the Beneficial Ownership Limitation will not be effective until the sixty-first (61st) day after such notice is delivered to the Company and any such increase or decrease will apply only to the Holder and its Affiliates and not to any other holder of Warrants. The provisions of this Section 3.3.9 shall be construed and implemented in a manner otherwise than in strict conformity with the terms of this Section 3.3.9 to correct this subsection (or any portion hereof) which may be defective or inconsistent with the intended beneficial ownership limitation herein contained.

 

	
	7
	

	

 

4. Adjustments.

 

4.1. Adjustment upon Subdivisions or Combinations. If the Company at any time after the Issuance Date subdivides (by any stock split, stock dividend, recapitalization, reorganization, scheme, arrangement or otherwise) its outstanding shares of Common Stock into a greater number of shares, the Exercise Price in effect immediately prior to such subdivision will be proportionately reduced and the number of Warrant Shares will be proportionately increased. If the Company at any time after the Issuance Date combines (by any stock split, stock dividend, recapitalization, reorganization, scheme, arrangement or otherwise) its outstanding shares of Common Stock into a smaller number of shares, the Exercise Price in effect immediately prior to such combination will be proportionately increased and the number of Warrant Shares will be proportionately decreased. Any adjustment under this Section 4.1 shall become effective at the close of business on the date the subdivision or combination becomes effective. The Company shall promptly notify Warrant Agent of any such adjustment and give specific instructions to Warrant Agent with respect to any adjustments to the warrant register.

 

4.2. Adjustment for Other Distributions. In the event the Company shall fix a record date for the making of a dividend or distribution to all holders of Common Stock of any evidences of indebtedness or assets or subscription rights, options or warrants (excluding those referred to in Section 4.1 or other dividends paid out of retained earnings), then in each such case the Holder will, upon the exercise of Warrants, be entitled to receive, in addition to the number of Warrant Shares issuable thereupon, and without payment of any additional consideration therefor, the amount of such dividend or distribution, as applicable, which such Holder would have held on the date of such exercise had such Holder been the holder of record of such Warrant Shares as of the date on which holders of Common Stock became entitled to receive such dividend or distribution. Such adjustment shall be made whenever any such distribution is made and shall become effective immediately after the record date mentioned above. 

 

	
	8
	

	

 

4.3. Reclassification, Consolidation, Purchase, Combination, Sale or Conveyance. If, at any time while the Warrants are outstanding, (a) the Company, directly or indirectly, in one or more related transactions effects any merger or consolidation of the Company with or into another person, (b) the Company, directly or indirectly, effects any sale, lease, license, assignment, transfer, conveyance or other disposition of all or substantially all of its assets in one or a series of related transactions, (c) any, direct or indirect, purchase offer, tender offer or exchange offer (whether by the Company or another person) is completed pursuant to which holders of Common Stock are permitted to sell, tender or exchange their shares for other securities, cash or property and has been accepted by the holders of 50% or more of the outstanding Common Stock (not including any Common Stock held by the other person or other persons making or party to, or associated or affiliated with the other persons making, such purchase offer, tender offer or exchange offer), (d) the Company, directly or indirectly, in one or more related transactions effects any reclassification, reorganization or recapitalization of the Common Stock or any compulsory share exchange pursuant to which the Common Stock is effectively converted into or exchanged for other securities, cash or property, or (e) the Company, directly or indirectly, in one or more related transactions consummates a stock or share purchase agreement or other business combination (including, without limitation, a reorganization, recapitalization, spin-off or scheme of arrangement) with another person whereby such other person acquires more than 50% of the outstanding shares of Common Stock (not including any shares of Common Stock held by the other person or other persons making or party to, or associated or affiliated with the other persons making or party to, such stock or share purchase agreement or other business combination) (each a “Fundamental Transaction”), then, upon any subsequent exercise of a Warrant, each Holder shall have the right to receive, for each Warrant Share that would have been issuable upon such exercise immediately prior to the occurrence of such Fundamental Transaction (without regard to any limitation in Section 3.3.9 on the exercise of the Warrants), the same amount and kind of securities, cash or property, if any, of the successor or acquiring corporation or of the Company, if it is the surviving corporation, and any additional consideration (the “Alternate Consideration”) receivable as a result of such Fundamental Transaction by a holder of the number of shares of Common Stock for which each Warrant is exercisable immediately prior to such Fundamental Transaction (without regard to any limitation in Section 3.3.9 on the exercise of the Warrants). For purposes of any such exercise, the determination of the Exercise Price shall be appropriately adjusted to apply to such Alternate Consideration based on the amount of Alternate Consideration issuable in respect of one share of Common Stock in such Fundamental Transaction, and the Company shall apportion the Exercise Price among the Alternate Consideration in a reasonable manner reflecting the relative value of any different components of the Alternate Consideration. If holders of Common Stock are given any choice as to the securities, cash or property to be received in a Fundamental Transaction, then the Holder shall be given the same choice as to the Alternate Consideration that such Holder receives upon any exercise of each Warrant following such Fundamental Transaction. The Company shall cause any successor entity in a Fundamental Transaction in which the Company is not the survivor (the “Successor Entity”) and for which shareholders received any equity securities of the Successor Entity and for which shareholders received any equity securities of the Successor Entity, to assume in writing all of the obligations of the Company under this Warrant Agreement in accordance with the provisions of this Section 4.3 pursuant to written agreements and shall, upon the written request of such Holder, deliver to such Holder in exchange for the applicable Warrants created by this Warrant Agreement a security of the Successor Entity evidenced by a written instrument substantially similar in form and substance to the Warrants which are exercisable for a corresponding number of shares of capital stock of such Successor Entity (or its parent entity), if any, plus any Alternate Consideration, receivable as a result of such Fundamental Transaction by a holder of the number of shares of Common Stock for which the Warrants are exercisable immediately prior to such Fundamental Transaction, and with an exercise price which applies the Exercise Price hereunder to such shares of capital stock, if any, plus any Alternate Consideration (but taking into account the relative value of the shares of Common Stock pursuant to such Fundamental Transaction and the value of such shares of capital stock plus Alternative consideration after that Fundamental Transaction for the purpose of protecting the economic value of such Warrant immediately prior to the consummation of such Fundamental Transaction). Upon the occurrence of any such Fundamental Transaction the Successor Entity shall succeed to, and be substituted for (so that from and after the date of such Fundamental Transaction, the provisions of this Warrant Agreement and the Warrants referring to the “Company” shall refer instead to the Successor Entity), and may exercise every right and power of the Company and shall assume all of the obligations of the Company under this Warrant Agreement and the Warrants with the same effect as if such Successor Entity had been named as the Company herein and therein. The Company shall instruct the Warrant Agent in writing to mail by first class mail, postage prepaid, to each Holder, written notice of the execution of any such amendment, supplement or agreement with the Successor Entity. Any supplemented or amended agreement entered into by the successor corporation or transferee shall provide for adjustments, which shall be as nearly equivalent as may be practicable to the adjustments provided for in this Section 4.3. The Warrant Agent shall have no duty, responsibility or obligation to determine the correctness of any provisions contained in such agreement or such notice, including but not limited to any provisions relating either to the kind or amount of securities or other property receivable upon exercise of warrants or with respect to the method employed and provided therein for any adjustments, and shall be entitled to rely conclusively for all purposes upon the provisions contained in any such agreement. The provisions of this Section 4.3 shall similarly apply to successive reclassifications, changes, consolidations, mergers, sales and conveyances of the kind described above. 

 

	
	9
	

	

 

4.4. Other Events. If any event occurs of the type contemplated by the provisions of Section 4.1 or 4.2 but not expressly provided for by such provisions (including, without limitation, the granting of stock appreciation rights, Adjustment Rights, phantom stock rights or other rights with equity features to all holders of Common Stock for no consideration), then the Company's Board of Directors will, at its discretion and in good faith, make an adjustment in the Exercise Price and the number of Warrant Shares or designate such additional consideration to be deemed issuable upon exercise of a Warrant, so as to protect the rights of the registered Holder. No adjustment to the Exercise Price will be made pursuant to more than one sub-section of this Section 4 in connection with a single issuance.

 

4.5. Notices of Changes in Warrant. Upon every adjustment of the Exercise Price or the number of Warrant Shares issuable upon exercise of a Warrant, the Company shall give written notice thereof to the Warrant Agent, which notice shall state the Exercise Price resulting from such adjustment and the increase or decrease, if any, in the number of Warrant Shares purchasable at such price upon the exercise of a Warrant, setting forth in reasonable detail the method of calculation and the facts upon which such calculation is based. Upon the occurrence of any event specified in Sections 4.1 or 4.2, then, in any such event, the Company shall give written notice to each Holder, at the last address set forth for such holder in the Warrant Register, as of the record date or the effective date of the event. Failure to give such notice, or any defect therein, shall not affect the legality or validity of such event. The Warrant Agent shall be entitled to rely conclusively on, and shall be fully protected in relying on, any certificate, notice or instructions provided by the Company with respect to any adjustment of the Exercise Price or the number of shares issuable upon exercise of a Warrant, or any related matter, and the Warrant Agent shall not be liable for any action taken, suffered or omitted to be taken by it in accordance with any such certificate, notice or instructions or pursuant to this Warrant Agreement. The Warrant Agent shall not be deemed to have knowledge of any such adjustment unless and until it shall have received written notice thereof from the Company.

 

5. Restrictive Legends; Fractional Warrants. In the event that a Warrant Certificate surrendered for transfer bears a restrictive legend, the Warrant Agent shall not register that transfer until the Warrant Agent has received an opinion of counsel for the Company stating that such transfer may be made and indicating whether the Warrants must also bear a restrictive legend upon that transfer. The Warrant Agent shall not be required to effect any registration of transfer or exchange which will result in the transfer of or delivery of a Warrant Certificate for a fraction of a Warrant.

 

	
	10
	

	

 

6. Other Provisions Relating to Rights of Holders of Warrants.

 

6.1. No Rights as Shareholder. Except as otherwise specifically provided herein, a Holder, solely in its capacity as a holder of Warrants, shall not be entitled to vote or receive dividends or be deemed the holder of share capital of the Company for any purpose, nor shall anything contained in this Warrant Agreement be construed to confer upon a Holder, solely in its capacity as the registered holder of Warrants, any of the rights of a shareholder of the Company or any right to vote, give or withhold consent to any corporate action (whether any reorganization, issue of stock, reclassification of share capital, consolidation, merger, conveyance or otherwise), receive notice of meetings, receive dividends or subscription rights or rights to participate in new issues of shares, or otherwise, prior to the issuance to the Holder of the Warrant Shares which it is then entitled to receive upon the due exercise of Warrants.

 

6.2. Reservation of Common Stock. The Company shall at all times reserve and keep available a number of its authorized but unissued shares of Common Stock that will be sufficient to permit the exercise in full of all outstanding Warrants issued pursuant to this Warrant Agreement.

 

7. Concerning the Warrant Agent and Other Matters.

 

7.1. Any instructions given to the Warrant Agent orally, as permitted by any provision of this Warrant Agreement, shall be confirmed in writing by the Company as soon as practicable. The Warrant Agent shall not be liable or responsible and shall be fully authorized and protected for acting, or failing to act, in accordance with any oral instructions which do not conform with the written confirmation received in accordance with this Section 7.1.

 

7.2. (a) Whether or not any Warrants are exercised, for the Warrant Agent’s services as agent for the Company hereunder, the Company shall pay to the Warrant Agent such fees as may be separately agreed between the Company and Warrant Agent and the Warrant Agent’s out of pocket expenses in connection with this Warrant Agreement, including, without limitation, the fees and expenses of the Warrant Agent’s counsel. While the Warrant Agent endeavors to maintain out-of-pocket charges (both internal and external) at competitive rates, these charges may not reflect actual out-of-pocket costs, and may include handling charges to cover internal processing and use of the Warrant Agent’s billing systems. (b) All amounts owed by the Company to the Warrant Agent under this Warrant Agreement are due within 30 days of the invoice date. Delinquent payments are subject to a late payment charge of one and one-half percent (1.5%) per month commencing 45 days from the invoice date. The Company agrees to reimburse the Warrant Agent for any attorney’s fees and any other costs associated with collecting delinquent payments. (c) No provision of this Warrant Agreement shall require Warrant Agent to expend or risk its own funds or otherwise incur any financial liability in the performance of any of its duties under this Warrant Agreement or in the exercise of its rights.

 

	
	11
	

	

 

7.3. As agent for the Company hereunder the Warrant Agent: (a) shall have no duties or obligations other than those specifically set forth herein or as may subsequently be agreed to in writing by the Warrant Agent and the Company; (b) shall be regarded as making no representations and having no responsibilities as to the validity, sufficiency, value, or genuineness of the Warrants or any Warrant Shares; (c) shall not be obligated to take any legal action hereunder; if, however, the Warrant Agent determines to take any legal action hereunder, and where the taking of such action might, in its judgment, subject or expose it to any expense or liability it shall not be required to act unless it has been furnished with an indemnity reasonably satisfactory to it; (e) may rely on and shall be fully authorized and protected in acting or failing to act upon any certificate, instrument, opinion, notice, letter, telegram, telex, facsimile transmission or other document or security delivered to the Warrant Agent and believed by it to be genuine and to have been signed by the proper party or parties; (f) shall not be liable or responsible for any recital or statement contained in the Registration Statement or any other documents relating thereto; (g) shall not be liable or responsible for any failure on the part of the Company to comply with any of its covenants and obligations relating to the Warrants, including without limitation obligations under applicable securities laws; (h) may rely on and shall be fully authorized and protected in acting or failing to act upon the written, telephonic or oral instructions with respect to any matter relating to its duties as Warrant Agent covered by this Warrant Agreement (or supplementing or qualifying any such actions) of officers of the Company, and is hereby authorized and directed to accept instructions with respect to the performance of its duties hereunder from the Company or counsel to the Company, and may apply to the Company, for advice or instructions in connection with the Warrant Agent’s duties hereunder, and the Warrant Agent shall not be liable for any delay in acting while waiting for those instructions; any applications by the Warrant Agent for written instructions from the Company may, at the option of the Agent, set forth in writing any action proposed to be taken or omitted by the Warrant Agent under this Warrant Agreement and the date on or after which such action shall be taken or such omission shall be effective; the Warrant Agent shall not be liable for any action taken by, or omission of, the Warrant Agent in accordance with a proposal included in such application on or after the date specified in such application (which date shall not be less than five business days after the date such application is sent to the Company, unless the Company shall have consented in writing to any earlier date) unless prior to taking any such action, the Warrant Agent shall have received written instructions in response to such application specifying the action to be taken or omitted; (i) may consult with counsel satisfactory to the Warrant Agent, including its in-house counsel, and the advice of such counsel shall be full and complete authorization and protection in respect of any action taken, suffered, or omitted by it hereunder in good faith and in accordance with the advice of such counsel; (j) may perform any of its duties hereunder either directly or by or through nominees, correspondents, designees, or subagents, and it shall not be liable or responsible for any misconduct or negligence on the part of any nominee, correspondent, designee, or subagent appointed with reasonable care by it in connection with this Warrant Agreement; (k) is not authorized, and shall have no obligation, to pay any brokers, dealers, or soliciting fees to any person; and (l) shall not be required hereunder to comply with the laws or regulations of any country other than the United States of America or any political subdivision thereof.

 

7.4. (a) In the absence of gross negligence or willful or illegal misconduct on its part, the Warrant Agent shall not be liable for any action taken, suffered, or omitted by it or for any error of judgment made by it in the performance of its duties under this Warrant Agreement. Anything in this Warrant Agreement to the contrary notwithstanding, in no event shall Warrant Agent be liable for special, indirect, incidental, consequential or punitive losses or damages of any kind whatsoever (including but not limited to lost profits), even if the Warrant Agent has been advised of the possibility of such losses or damages and regardless of the form of action. Any liability of the Warrant Agent will be limited in the aggregate to the amount of fees paid by the Company hereunder. The Warrant Agent shall not be liable for any failures, delays or losses, arising directly or indirectly out of conditions beyond its reasonable control including, but not limited to, acts of government, exchange or market ruling, suspension of trading, work stoppages or labor disputes, fires, civil disobedience, riots, rebellions, storms, electrical or mechanical failure, computer hardware or software failure, communications facilities failures including telephone failure, war, terrorism, insurrection, earthquakes, floods, acts of God or similar occurrences. (b) In the event any question or dispute arises with respect to the proper interpretation of the Warrants or the Warrant Agent’s duties under this Warrant Agreement or the rights of the Company or of any Holder, the Warrant Agent shall not be required to act and shall not be held liable or responsible for its refusal to act until the question or dispute has been judicially settled (and, if appropriate, it may file a suit in interpleader or for a declaratory judgment for such purpose) by final judgment rendered by a court of competent jurisdiction, binding on all persons interested in the matter which is no longer subject to review or appeal, or settled by a written document in form and substance satisfactory to Warrant Agent and executed by the Company and each such Holder. In addition, the Warrant Agent may require for such purpose, but shall not be obligated to require, the execution of such written settlement by all the Holders and all other persons that may have an interest in the settlement.

 

	
	12
	

	

 

7.5. The Company covenants to indemnify the Warrant Agent and hold it harmless from and against any loss, liability, claim or expense (“Loss”) arising out of or in connection with the Warrant Agent’s duties under this Warrant Agreement, including the costs and expenses of defending itself against any Loss, unless such Loss shall have been determined by a court of competent jurisdiction to be a result of the Warrant Agent’s gross negligence or willful misconduct.

 

7.6. Unless terminated earlier by the parties hereto, this Agreement shall terminate 90 days after the earlier of the Expiration Date and the date on which no Warrants remain outstanding (the “Termination Date”). On the business day following the Termination Date, the Agent shall deliver to the Company any entitlements, if any, held by the Warrant Agent under this Warrant Agreement. The Agent’s right to be reimbursed for fees, charges and out-of-pocket expenses as provided in this Section 8 shall survive the termination of this Warrant Agreement.

 

7.7. If any provision of this Warrant Agreement shall be held illegal, invalid, or unenforceable by any court, this Warrant Agreement shall be construed and enforced as if such provision had not been contained herein and shall be deemed an Agreement among the parties to it to the full extent permitted by applicable law.

 

7.8. The Company represents and warrants that: (a) it is duly incorporated and validly existing under the laws of its jurisdiction of incorporation; (b) the offer and sale of the Warrants and the execution, delivery and performance of all transactions contemplated thereby (including this Warrant Agreement) have been duly authorized by all necessary corporate action and will not result in a breach of or constitute a default under the articles of association, bylaws or any similar document of the Company or any indenture, agreement or instrument to which it is a party or is bound; (c) this Warrant Agreement has been duly executed and delivered by the Company and constitutes the legal, valid, binding and enforceable obligation of the Company; (d) the Warrants will comply in all material respects with all applicable requirements of law; and (e) to the best of its knowledge, there is no litigation pending or threatened as of the date hereof in connection with the offering of the Warrants.

 

7.9. In the event of inconsistency between this Warrant Agreement and the descriptions in the Registration Statement, as they may from time to time be amended, the terms of this Warrant Agreement shall control.

 

7.10. Set forth in Exhibit C hereto is a list of the names and specimen signatures of the persons authorized to act for the Company under this Warrant Agreement (the “Authorized Representatives”). The Company shall, from time to time, certify to you the names and signatures of any other persons authorized to act for the Company under this Warrant Agreement.

 

7.11. Except as expressly set forth elsewhere in this Warrant Agreement, all notices, instructions and communications under this Agreement shall be in writing, shall be effective upon receipt and shall be addressed, if to the Company, to its address set forth beneath its signature to this Agreement, or, if to the Warrant Agent, to VStock Transfer, LLC 18 Lafayette Place, Woodmere, New York 11598, or to such other address of which a party hereto has notified the other party.

 

	
	13
	

	

 

7.12. (a) This Warrant Agreement shall be governed by and construed in accordance with the laws of the State of New York. All actions and proceedings relating to or arising from, directly or indirectly, this Warrant Agreement may be litigated in courts located within the Borough of Manhattan in the City and State of New York. The Company hereby submits to the personal jurisdiction of such courts and consents that any service of process may be made by certified or registered mail, return receipt requested, directed to the Company at its address last specified for notices hereunder. Each of the parties hereto hereby waives the right to a trial by jury in any action or proceeding arising out of or relating to this Warrant Agreement. (b) This Warrant Agreement shall inure to the benefit of and be binding upon the successors and assigns of the parties hereto. This Warrant Agreement may not be assigned, or otherwise transferred, in whole or in part, by either party without the prior written consent of the other party, which the other party will not unreasonably withhold, condition or delay; except that (i) consent is not required for an assignment or delegation of duties by Warrant Agent to any affiliate of Warrant Agent and (ii) any reorganization, merger, consolidation, sale of assets or other form of business combination by Warrant Agent or the Company shall not be deemed to constitute an assignment of this Warrant Agreement. (c) No provision of this Warrant Agreement may be amended, modified or waived, except in a written document signed by both parties. The Company and the Warrant Agent may amend or supplement this Warrant Agreement without the consent of any Holder for the purpose of curing any ambiguity, or curing, correcting or supplementing any defective provision contained herein or adding or changing any other provisions with respect to matters or questions arising under this Agreement as the parties may deem necessary or desirable and that the parties determine, in good faith, shall not adversely affect the interest of the Holders. All other amendments and supplements shall require the vote or written consent of Holders of at least 50.1% of the then outstanding Warrants, provided that adjustments may be made to the Warrant terms and rights in accordance with Section 4 without the consent of the Holders.

 

7.13. Payment of Taxes. The Company will from time to time promptly pay all taxes and charges that may be imposed upon the Company or the Warrant Agent in respect of the issuance or delivery of Warrant Shares upon the exercise of Warrants, but the Company may require the Holders to pay any transfer taxes in respect of the Warrants or such shares. The Warrant Agent may refrain from registering any transfer of Warrants or any delivery of any Warrant Shares unless or until the persons requesting the registration or issuance shall have paid to the Warrant Agent for the account of the Company the amount of such tax or charge, if any, or shall have established to the reasonable satisfaction of the Company and the Warrant Agent that such tax or charge, if any, has been paid. 

 
	 
	14
	

 
	 

 

7.14. Resignation of Warrant Agent.

 

7.14.1. Appointment of Successor Warrant Agent. The Warrant Agent, or any successor to it hereafter appointed, may resign its duties and be discharged from all further duties and liabilities hereunder after giving thirty (30) days’ notice in writing to the Company, or such shorter period of time agreed to by the Company. The Company may terminate the services of the Warrant Agent, or any successor Warrant Agent, after giving thirty (30) days’ notice in writing to the Warrant Agent or successor Warrant Agent, or such shorter period of time as agreed. If the office of the Warrant Agent becomes vacant by resignation, termination or incapacity to act or otherwise, the Company shall appoint in writing a successor Warrant Agent in place of the Warrant Agent. If the Company shall fail to make such appointment within a period of 30 days after it has been notified in writing of such resignation or incapacity by the Warrant Agent, then the Warrant Agent or any Holder may apply to any court of competent jurisdiction for the appointment of a successor Warrant Agent at the Company’s cost. Pending appointment of a successor to such Warrant Agent, either by the Company or by such a court, the duties of the Warrant Agent shall be carried out by the Company. Any successor Warrant Agent (but not including the initial Warrant Agent), whether appointed by the Company or by such court, shall be a person organized and existing under the laws of any state of the United States of America, in good standing, and authorized under such laws to exercise corporate trust powers and subject to supervision or examination by federal or state authority. After appointment, any successor Warrant Agent shall be vested with all the authority, powers, rights, immunities, duties, and obligations of its predecessor Warrant Agent with like effect as if originally named as Warrant Agent hereunder, without any further act or deed, and except for executing and delivering documents as provided in the sentence that follows, the predecessor Warrant Agent shall have no further duties, obligations, responsibilities or liabilities hereunder, but shall be entitled to all rights that survive the termination of this Warrant Agreement and the resignation or removal of the Warrant Agent, including but not limited to its right to indemnity hereunder. If for any reason it becomes necessary or appropriate or at the request of the Company, the predecessor Warrant Agent shall execute and deliver, at the expense of the Company, an instrument transferring to such successor Warrant Agent all the authority, powers, and rights of such predecessor Warrant Agent hereunder; and upon request of any successor Warrant Agent the Company shall make, execute, acknowledge, and deliver any and all instruments in writing for more fully and effectually vesting in and confirming to such successor Warrant Agent all such authority, powers, rights, immunities, duties, and obligations.

 

7.14.2. Notice of Successor Warrant Agent. In the event a successor Warrant Agent shall be appointed, the Company shall give notice thereof to the predecessor Warrant Agent and the transfer agent for the Common Stock not later than the effective date of any such appointment.

 

7.14.3. Merger or Consolidation of Warrant Agent. Any person into which the Warrant Agent may be merged or converted or with which it may be consolidated or any person resulting from any merger, conversion or consolidation to which the Warrant Agent shall be a party or any person succeeding to the shareowner services business of the Warrant Agent or any successor Warrant Agent shall be the successor Warrant Agent under this Warrant Agreement, without any further act or deed. For purposes of this Warrant Agreement, “person” shall mean any individual, firm, corporation, partnership, limited liability company, joint venture, association, trust or other entity, and shall include any successor (by merger or otherwise) thereof or thereto.

 

	 
	15
	

 
	 

 

8. Miscellaneous Provisions.

 

8.1. Persons Having Rights under this Warrant Agreement. Nothing in this Warrant Agreement expressed and nothing that may be implied from any of the provisions hereof is intended, or shall be construed, to confer upon, or give to, any person or corporation other than the parties hereto and the Holders any right, remedy, or claim under or by reason of this Warrant Agreement or of any covenant, condition, stipulation, promise, or agreement hereof.

 

8.2. Examination of the Warrant Agreement. A copy of this Warrant Agreement shall be available at all reasonable times at the office of the Warrant Agent designated for such purpose for inspection by any Holder. Prior to such inspection, the Warrant Agent may require any such holder to provide reasonable evidence of its interest in the Warrants.

 

8.3. Counterparts. This Warrant Agreement may be executed in any number of original, facsimile or electronic counterparts and each of such counterparts shall for all purposes be deemed to be an original, and all such counterparts shall together constitute but one and the same instrument.

 

8.4. Effect of Headings. The Section headings herein are for convenience only and are not part of this Warrant Agreement and shall not affect the interpretation thereof.

 

9. Certain Definitions. As used herein, the following terms shall have the following meanings:

 

(a) “Adjustment Right” means any right granted with respect to any securities issued in connection with, or with respect to, any issuance, sale or delivery (or deemed issuance, sale or delivery in accordance with Section 4) of Common Stock (other than rights of the type described in Section 4.2 and 4.3 hereof) that could result in a decrease in the net consideration received by the Company in connection with, or with respect to, such securities (including, without limitation, any cash settlement rights, cash adjustment or other similar rights).

 

	 
	16
	

 
	 

 

(b) “Trading Day” means any day on which the Common Stock is traded on the Trading Market, or, if the Trading Market is not the principal trading market for the Common Stock, then on the principal securities exchange or securities market in the United States on which the Common Stock is then traded, provided that “Trading Day” shall not include any day on which the Common Stock is are scheduled to trade on such exchange or market for less than 4.5 hours or any day that the Common Stock is suspended from trading during the final hour of trading on such exchange or market (or if such exchange or market does not designate in advance the closing time of trading on such exchange or market, then during the hour ending at 4:00 P.M., New York City time).

 

(c) “Trading Market” means NYSE MKT, the Nasdaq Capital Market, the Nasdaq Global Market, the Nasdaq Global Select Market or the New York Stock Exchange.

 

(d) “VWAP” means, for any date, the price determined by the first of the following clauses that applies: (i) if the Common Stock is then listed or quoted on a Trading Market, the daily volume weighted average price of the Common Stock for such date (or the nearest preceding date) on the Trading Market on which the Common Stock is then listed or quoted as reported by Bloomberg L.P. (based on a Trading Day from 9:30 a.m. (New York City time) to 4:02 p.m. (New York City time)); (ii) the volume weighted average price of the Common Stock for such date (or the nearest preceding date) on the OTC Bulletin Board; (iii) if the Common Stock are not then listed or quoted for trading on the OTC Bulletin Board and if prices for the Common Stock are then reported in the OTCQB maintained by OTC Markets Group, Inc. (or a similar organization or agency succeeding to its functions of reporting prices), the most recent bid price per share of Common Stock so reported; or (iv) in all other cases, the fair market value of the Common Stock as determined by an independent appraiser selected in good faith by the Company, the fees and expenses of which shall be paid by the Company.

 

[Signature Page to Follow]

 

	 
	17
	

 
	 

 

IN WITNESS WHEREOF, this Warrant Agent Agreement has been duly executed by the parties hereto as of the day and year first above written.

 

	 	CITIUS PHARMACEUTICALS, INC.	
	 	 	 	 
		By:		
	
 
	
Name:
		 
	 	Title:		 
	 	 	 	 
	
 
	
VSTOCK TRANSFER, LLC
	
 

	
 
	
 
	
 
	
 

	
 
	
By:
	
 
	
 

	
 
	
Name:
	
 
	
 

	
 
	
Title:
	
 
	
 

 

	 
	18
	

 
	 

 

EXHIBIT A

 

[TO BE INCLUDED IN THE GLOBAL CERTIFICATE]

 

[UNLESS THIS CERTIFICATE IS PRESENTED BY AN AUTHORIZED REPRESENTATIVE OF THE DEPOSITORY TRUST COMPANY, A NEW YORK CORPORATION (“DTC”), TO ISSUER OR ITS AGENT FOR REGISTRATION OF TRANSFER, EXCHANGE, OR PAYMENT, AND ANY CERTIFICATE ISSUED IS REGISTERED IN THE NAME OF CEDE&NBSP;& CO. OR IN SUCH OTHER NAME AS IS REQUESTED BY AN AUTHORIZED REPRESENTATIVE OF DTC (AND ANY PAYMENT IS MADE TO CEDE&NBSP;& CO. OR TO SUCH OTHER ENTITY AS IS REQUESTED BY AN AUTHORIZED REPRESENTATIVE OF DTC), ANY TRANSFER, PLEDGE, OR OTHER USE HEREOF FOR VALUE OR OTHERWISE BY OR TO ANY PERSON IS WRONGFUL INASMUCH AS THE REGISTERED OWNER HEREOF, CEDE&NBSP;& CO., HAS AN INTEREST HEREIN.]

 

CITIUS PHARMACEUTICALS, INC.

WARRANT CERTIFICATE

NOT EXERCISABLE AFTER ____________________

 

This certifies that the person whose name and address appears below, or registered assigns, is the registered owner of the number of Warrants set forth below. Each Warrant entitles its registered holder to purchase from Citius Pharmaceuticals, Inc., a company incorporated under the laws of the State of Nevada (the “Company”), at any time prior to 5:00 P.M. (New York City time) on ________________, one share of common stock, par value $0.0001 per share, of the Company (each, a “Warrant Share” and collectively, the “Warrant Shares”), at an exercise price of $____ per share, subject to possible adjustments as provided in the Warrant Agreement (as defined below). 

 

This Warrant Certificate, with or without other Warrant Certificates, upon surrender at the designated office of the Warrant Agent, may be exchanged for another Warrant Certificate or Warrant Certificates evidencing the same number of Warrants as the Warrant Certificate or Warrant Certificates surrendered. A transfer of the Warrants evidenced hereby may be registered upon surrender of this Warrant Certificate at the designated office of the Warrant Agent by the registered holder in person or by a duly authorized attorney, properly endorsed or accompanied by proper instruments of transfer, a signature guarantee, and such other and further documentation as the Warrant Agent may reasonably request and duly stamped as may be required by the laws of the State of New York and of the United States of America.

 

The terms and conditions of the Warrants and the rights and obligations of the holder of this Warrant Certificate are set forth in the Warrant Agent Agreement dated as of ____________ (the “Warrant Agreement”) between the Company and VStock Transfer, LLC (the “Warrant Agent”). A copy of the Warrant Agreement is available for inspection during business hours at the office of the Warrant Agent.

 

This Warrant Certificate shall not be valid or obligatory for any purpose until it shall have been countersigned by an authorized signatory of the Warrant Agent.

 

	 
	19
	

 
	 

 

WITNESS the facsimile signature of a proper officer of the Company.

 

	 	CITIUS PHARMACEUTICALS, INC.	
	 	 	 	 
		By:		
	
 
	
Name:
		 
	 	Title:		 

 

Dated: _______________

 

Countersigned:

 

VSTOCK TRANSFER, LLC

 

By: ______________________________

Name: ____________________________

Title: _____________________________

 

	
PLEASE DETACH HERE 

	
 

 

Certificate No.:_________ Number of Warrants:__________

 

WARRANT CUSIP NO.: ___________

 

CITIUS PHARMACEUTICALS, INC. 

 
	 
	20
	

 
	 

 

EXHIBIT B

 

[Form of Election to Purchase]

 

(To Be Executed Upon Exercise Of Warrants not evidenced by a Global Certificate)

 

The undersigned hereby irrevocably elects to exercise the right, represented by Warrants evidenced by this Warrant Certificate, to receive ____________ Warrant Shares and herewith tenders payment for such Warrant Shares to the order of _______________________, in the amount of $ _________ in accordance with the terms hereof.

 

OR

 

[In cases where cashless exercise is permitted under the Warrant Agreement] – The undersigned hereby irrevocably elects to exercise the right, represented by Warrants evidenced by this Warrant Certificate, to receive _____________ Warrant Shares (before giving effect to the cashless exercise provisions) and herewith agrees to make payment therefor pursuant to the cashless exercise provisions of the Warrant Agreement, all on the terms and the conditions specified in the Warrant Agent Agreement.

 

The undersigned requests that a certificate for such Warrant Shares be registered in the name of ___________________________, whose address is _____________________________ and that such certificate be delivered to _______________________________, whose address is _____________________________________. If the number of Warrants being exercised hereby is less than all the Warrants evidenced by this Warrant Certificate, the undersigned requests that a new Warrant Certificate representing the remaining unexercised Warrants be registered in the name of ___________________________, whose address is _____________________________ and that such Warrant Certificate be delivered to ______________________________________ whose address is _________________________________.

 

 

	 	Signature,	
	 	 	 
	Date:		
	
 
		 
	 	[Signature Guarantee] 	 

 

Signatures must be guaranteed by an “eligible guarantor institution” meeting the requirements of the Warrant Agent, which requirements include membership or participation in the Security Transfer Agent Medallion Program (“STAMP”) or such other “signature guarantee program” as may be determined by the Warrant Agent in addition to, or in substitution for, STAMP, all in accordance with the Securities Exchange Act of 1934, as amended

 

	 
	21
	

 
	 

 

EXHIBIT C

 

AUTHORIZED REPRESENTATIVES

 

	
Name
	

	
Title
	

	
Signature

					
					

 

 

 
	22EXHIBIT 10.1

THIRD AMENDED AND RESTATED

EMPLOYMENT AGREEMENT

THIS THIRD AMENDED AND
RESTATED EMPLOYMENT AGREEMENT (the
“Agreement”), is being entered into this June 16, 2017 (the “Effective Date”),
by and between WELLTOWER INC., a Delaware corporation, (the
“Corporation”), and SCOTT A. ESTES (the “Executive”).

WHEREAS, Executive and the Corporation previously entered
into a Second Amended and Restated Employment Agreement, dated December 29,
2008 (the “Prior Employment Agreement”); and 

WHEREAS, the Parties desire to amend and restate the Prior
Employment Agreement so that the Executive continues to act as the
Corporation’s Executive Vice President – Chief Financial Officer based on the
terms and conditions set forth herein.

NOW THEREFORE, in consideration of the mutual covenants herein
contained, the parties, intending to be legally bound, hereby agree as follows:

1.                 
EMPLOYMENT 

The Corporation hereby agrees to
continue to employ the Executive as the Corporation’s Executive Vice President
– Chief Financial Officer, upon the terms and conditions herein contained, and
the Executive hereby agrees to continue such employment and to continue to
serve in such positions, and to perform the duties and functions customarily
performed by the Executive Vice President – Chief Financial Officer of a
publicly traded corporation.

In such capacity, the Executive
shall report to the Corporation’s Chief Executive Officer (“CEO”) and shall
have such powers and responsibilities set forth in the Corporation’s By-Laws as
well as such additional powers and responsibilities consistent with his
position as may be assigned by the CEO.

Throughout the Term (defined
below) of this Agreement, the Executive shall devote his best efforts and all
of his business time and services to the business and affairs of the
Corporation; provided, that the Executive will be permitted to, with the prior
written approval of the CEO, act or serve as a director, trustee or committee
member of a commercial business, civic or charitable organization.

2.                 
TERM OF AGREEMENT

The term of employment under
this Agreement shall expire on January 31, 2019, unless earlier terminated
under one of the circumstances set forth in Sections 5, 6 or 7.  As used
herein, “Term” refers to the length of the Executive’s employment under this
Agreement, but the Term shall end upon any termination of Executive’s
employment with the Corporation as provided herein.  Notwithstanding the
foregoing, if a Change in Corporate Control (as defined in Section 6(b)) occurs
during the Term, the Term shall be extended until twenty-four (24) months after
the Change in Corporate Control.

The Corporation shall be
entitled to terminate this Agreement and the Executive’s employment immediately
for any reason or no reason, subject to the continuing obligations of the
Corporation under this Agreement.  Upon termination of the Executive’s
employment hereunder, unless otherwise expressly provided by the Corporation’s
Board of Directors (the “Board”), the Executive shall be deemed to have
resigned from all positions that the Executive holds as an officer of the
Corporation or any of its affiliates.

3.                 
BASE COMPENSATION AND BONUS

(a)                
The Executive shall receive annual
base compensation during the Term of this Agreement of not less than $510,000
in cash (“Base Compensation”).  Such amounts shall be payable in substantially
equal semi-monthly installments in accordance with the Corporation’s customary
payroll practices.  Subject to the terms of this Agreement, during the Term,
the Compensation Committee of the Board (the “Compensation Committee”) shall
consult with the CEO and review the Executive’s Base Compensation at annual
intervals, and may adjust the Executive’s annual Base Compensation from time to
time.

(b)               
The Executive shall also be
eligible to receive an annual incentive cash bonus for each calendar year
ending during the Term of this Agreement, with the actual amount of such bonus
to be determined by the Compensation Committee, using such performance measures
as the Compensation Committee deems to be appropriate.  Such bonus, if any,
shall be paid to the Executive no 

1

  

 

later than sixty (60)
days after the end of the year to which the bonus relates.  Except as otherwise
provided in Sections 5 or 6, (i) the annual bonus will be subject to the terms
of any Corporation bonus plan under which it is granted and (ii) in order to be
eligible to receive an annual bonus, the Executive must be employed by the
Corporation on the last day of the applicable calendar year.

4.                 
ADDITIONAL COMPENSATION AND
BENEFITS

The Executive shall receive the
following additional compensation and welfare and fringe benefits during the
Term:

(a)                
Long-Term Incentives.  During the Term of the Agreement, any stock
options, restricted stock or other awards granted under the 2016 Long-Term
Incentive Plan shall be at the discretion of the Compensation Committee.

(b)               
Health Insurance.  During the Term of this Agreement, the Corporation
shall provide the Executive and his dependents with health insurance, life
insurance and disability coverage no less favorable than that from time to time
made available to other key employees.

(c)                
Paid Time Off.  During the Term of this Agreement, the Executive
shall be entitled to paid time off (“PTO”) (based on the number of years of
service) in accordance with the Corporation’s PTO policy, as it may be amended
from time to time.

(d)               
Business Expenses.  During the Term of this Agreement, the Corporation
shall reimburse the Executive for all reasonable expenses he incurs in
promoting the Corporation’s business, including expenses for travel and similar
items, upon presentation by the Executive from time to time of an itemized
account of such expenditures in accordance with the Corporation’s established
policies and applicable law.  Following Executive’s termination of employment,
any expense reimbursement requests must be submitted no later than sixty (60)
days following such termination.

(e)                
Other Benefits.  In addition to the benefits provided pursuant to
the preceding paragraphs of this Section 4, the Executive shall be eligible to
participate in such other executive compensation and retirement plans of the
Corporation as are applicable generally to other officers, and in such welfare
plans, programs, practices and policies of the Corporation as are generally
applicable to other key employees, unless such participation would duplicate,
directly or indirectly, benefits already accorded to the Executive.

5.                 
PAYMENTS UPON TERMINATION

(a)                
Termination without Cause or
Termination by Executive for Good Reason (as defined below).  If the Executive’s employment is terminated by the
Corporation without Cause (but not including due to death or Disability) or
terminated by the Executive for Good Reason during the Term of this Agreement,
the Executive shall be entitled to the following:

(i)                 
Base Compensation accrued through
the date of termination, based on the number of days in such year that had
elapsed as of the termination date;

(ii)               
any accrued but unpaid PTO through
the date of termination;

(iii)             
any bonuses earned but unpaid with
respect to fiscal years or other completed bonus periods preceding the
termination date;

(iv)              
any nonforfeitable benefits
payable to the Executive under the terms of any deferred compensation,
incentive or other benefit plans maintained by the Corporation, payable in
accordance with the terms of the applicable plan;

(v)               
any expenses owed to the Executive
under Section 4(d);

(vi)              
any pro-rated portion of the
annual bonus that the Executive would have earned for the year in which the
termination occurs (if he had remained employed for the entire year), based on
the number of days in such year that had elapsed as of the termination date,
payable at the time that the Corporation pays bonuses to its executive officers
for such year;

(vii)            
all of Executive’s outstanding
stock options, restricted stock or other equity awards with time-based vesting
shall become fully vested and, in the case of stock options, exercisable in
full, and the Executive shall have the right to exercise such stock options
during a period of ninety (90) days following the termination of employment;

 

2

  

 

(viii)          
the treatment of all of
Executive’s outstanding stock options, restricted stock, restricted stock units
or other equity awards with performance-based vesting shall be determined in
accordance with the long-term incentive plan, and any other plans, pursuant to
which such awards were granted and the applicable award agreement;

(ix)              
continued coverage under any group
health plan maintained by the Corporation in which the Executive participated
at the time of his termination for the remainder of the Term of the Agreement
(but not less than six (6) months and not more than the period during which the
Executive would be entitled to continuation coverage under Section 4980B of the
Code, if the Executive elected such coverage and paid the applicable premiums),
or until, if earlier, the date the Executive obtains comparable coverage under
benefit plans maintained by a new employer, at an after-tax cost to the
Executive comparable to the cost that the Executive would have incurred for the
same coverage had he remained employed during such period; and

(x)               
a series of semi-monthly severance
payments for each complete calendar month during the remaining Term of this
Agreement, but not less than twelve (12) months (the “Severance Period”), each
semi-monthly payment in an amount equal to one-twenty fourth (1/24th) of the
sum of (A) the Executive’s Base Compensation, as in effect on the date of
termination, and (B) the greater of (1) the annual bonus paid to the Executive
for the last fiscal year preceding the termination date or (2) a minimum bonus
equal to thirty-five percent (35%) of Executive’s Base Compensation.

Notwithstanding anything in the
long-term incentive plan, and any other plans, pursuant to which any equity
awards are granted, or any applicable equity award agreements to the contrary,
the payments set forth in subsections (vi), (vii), (viii), (ix) and (x) are
subject to (a) a waiver and general release of claims in favor of the
Corporation, in a form and manner satisfactory to the Corporation, that is
executed by the Executive and which becomes irrevocable within sixty (60) days
following the date of such termination, and (b) the Executive’s compliance with
the restrictive covenants set forth in Sections 9 and 10 below during the
Severance Period (the “Severance Requirement”).  Notwithstanding anything in
the 2016 Long-Term Incentive Plan, any other plans pursuant to which any equity
awards are granted, or any applicable equity award agreements to the contrary,
upon any violation of the Severance Requirement during the Severance Period,
all post-employment compensation set forth in subsections (vi), (vii), (viii),
(ix) and (x) above shall immediately stop and the Executive shall be obligated
to return to the Corporation any post-employment compensation previously paid
or otherwise provided to the Executive.  The pro-rated bonus payable pursuant
to subsection (vi) shall be paid in accordance with the provisions of Section
3(b) after the Compensation Committee has approved bonuses payable for the
year.  All payments to be made or settlements to occur pursuant to subsection
(vii) and (viii) (excluding stock options) shall be made to the Executive on
the first business day following the date that is sixty (60) days following the
date of such termination (except as otherwise expressly provided in the
applicable award agreement).  The payments set forth in subsection (x) shall
commence on the 60th day following the date of such termination.

All payments required to be made
pursuant to subsections (i), (ii), (iii), and (v) shall be made to the Executive
within sixty (60) days following the date of such termination and within any
shorter time period required by law.

For purposes of this Agreement,
“Cause” shall mean: (1) any action by the Executive involving willful
disloyalty to the Corporation, such as embezzlement, fraud, misappropriation of
corporate assets or a breach of the covenants set forth in Section 9 or 10
herein; (2) the Executive being convicted of a felony; (3) the Executive being
convicted of any crime or offense that is not a felony but was (x) committed in
connection with the performance of his duties hereunder or (y) involved
moral turpitude; or (4) the intentional and willful failure by the Executive to
substantially perform his duties hereunder as directed by the CEO (other than
any such failure resulting from the Executive’s incapacity due to physical or
mental disability) after a demand for substantial performance is made by the
Board.  For purposes of this Agreement, “Good Reason” shall mean: (1) the
assignment of Executive to a position other than Executive Vice President –
Chief Financial Officer (other than for Cause or by reason of disability), (2)
the assignment of duties materially inconsistent with such position if such
change in assignment constitutes (x) a material diminution in the Executive’s
authority, duties or responsibilities, or (y) a change in the reporting
structure such that the Executive is directed to report to anyone other than
the Corporation’s CEO, or (3) a material breach by the Corporation of this Agreement;
provided, however, Executive must not have consented to any such act or
omission that could give rise to a claim for “Good Reason”, the Executive must
have notified the Corporation in writing within the first thirty (30) days
following the occurrence of any of the foregoing events and the Corporation
must have failed to substantially cure such breach within thirty (30) days
following its receipt of such notice from the Executive; and provided further,
the Executive must have resigned under this paragraph within ninety (90) days
following the occurrence of the event.  Notwithstanding the foregoing, any
transfer of responsibilities in connection with succession planning and
leadership transition shall in no event constitute Good Reason for purposes of
this Agreement.

(b)               
Disability.  The Corporation shall be entitled to terminate the
Executive’s employment if the Board determines that the Executive has been
unable to engage in any substantial gainful activity by reason of any medically
determinable physical or mental impairment that can be expected to result in
death or which has lasted or can be expected to last for a continuous period of
not less than 

3

  

 

12 months, and the permanence and degree
of which shall be supported by medical evidence satisfactory to the Committee
(“Disability”).  Upon such termination, the Executive shall be entitled to the
following:

(i)                 
Base Compensation accrued through
the date of termination, based on the number of days in such year that had
elapsed as of the termination date;

(ii)               
any accrued but unpaid PTO through
the date of termination;

(iii)             
any bonuses earned but unpaid with
respect to fiscal years or other completed bonus periods preceding the
termination date;

(iv)              
any nonforfeitable benefits
payable to the Executive under the terms of any deferred compensation,
incentive or other benefit plans maintained by the Corporation, payable in
accordance with the terms of the applicable plan;

(v)               
any expenses owed to the Executive
under Section 4(d);

(vi)              
any pro-rated portion of the
annual bonus that the Executive would have earned for the year in which the
termination occurs (if he had remained employed for the entire year), based on
the number of days in such year that had elapsed as of the termination date,
payable at the time that the Corporation pays bonuses to its executive officers
for such year; and 

(vii)            
the treatment of all of
Executive’s outstanding stock options, restricted stock, restricted stock units
or other equity awards (whether subject to time-based vesting or
performance-based vesting) shall be determined in accordance with the long-term
incentive plan, and any other plans, pursuant to which such awards were granted
and the applicable award agreement.

All payments required to be made
pursuant to subsections (i), (ii), (iii) and (v) shall be made to the Executive
within sixty (60) days following the date of such termination and within any
shorter time period required by law.  The pro-rated bonus payable pursuant to
subsection (vi) shall be paid in accordance with the provisions of Section 3(b)
after the Compensation Committee has approved bonuses payable for the year.

(c)                
Termination for Cause.  If the Executive’s employment is terminated by the
Corporation for Cause, the Executive shall be entitled to the following:

(i)                 
Base Compensation accrued through
the date of termination, based on the number of days in such year that had
elapsed as of the termination date;

(ii)               
any accrued but unpaid PTO through
the date of termination;

(iii)             
any bonuses earned but unpaid with
respect to fiscal years or other completed bonus periods preceding the
termination date;

(iv)              
any nonforfeitable benefits
payable to the Executive under the terms of any deferred compensation,
incentive or other benefit plans maintained by the Corporation, payable in
accordance with the terms of the applicable plan; and

(v)               
any expenses owed to the Executive
under Section 4(d).

All
payments required to be made pursuant to subsections (i), (ii), (iii) and (v)
shall be made to the Executive within sixty (60) days following the date of
such termination and within any shorter time period required by law.

(d)               
Voluntary Termination or
Resignation by the Executive.  If the
Executive voluntarily terminates (but not by reason of expiration of the Term)
or resigns his employment other than for Good Reason, the Executive shall be entitled
to the following:

(i)                 
Base Compensation accrued through
the date of termination, based on the number of days in such year that had
elapsed as of the termination date;

(ii)               
any accrued but unpaid PTO through
the date of termination;

 

4

  

 

(iii)             
any bonuses earned but unpaid with
respect to fiscal years or other completed bonus periods preceding the
termination date;

(iv)              
any nonforfeitable benefits
payable to the Executive under the terms of any deferred compensation,
incentive or other benefit plans maintained by the Corporation, payable in
accordance with the terms of the applicable plan; and

(v)               
any expenses owed to the Executive
under Section 4(d).

All payments required to be made
pursuant to subsections (i), (ii), (iii) and (v) shall be made to the Executive
within sixty (60) days following the date of such termination and within any
shorter time period required by law.

(e)                
Termination upon Expiration of
the Term.  If the Executive’s
employment terminates as a result of the expiration of the Term of this
Agreement, the Executive shall be entitled to the following:

(i)                 
Base Compensation accrued through
the date of termination, based on the number of days in such year that had
elapsed as of the termination date;

(ii)               
any accrued but unpaid PTO through
the date of termination;

(iii)             
any bonuses earned but unpaid with
respect to fiscal years or other completed bonus periods preceding the
termination date;

(iv)              
any nonforfeitable benefits
payable to the Executive under the terms of any deferred compensation,
incentive or other benefit plans maintained by the Corporation, payable in
accordance with the terms of the applicable plan; and

(v)               
any expenses owed to the Executive
under Section 4(d).

All payments required to be made
pursuant to subsections (i), (ii), (iii) and (v) shall be made to the Executive
within sixty (60) days following the date of such termination and within any
shorter time period required by law.

(f)                 
Cooperation.  The parties agree that certain matters in which the
Executive will be involved during the Term of this Agreement may necessitate
the Executive’s cooperation in the future.  Accordingly, following the
termination of the Executive’s employment for any reason, to the extent
reasonably requested by the CEO or the Board, the Executive shall cooperate
with the Corporation in connection with matters arising out of the Executive’s
service to the Corporation; provided that, the Corporation shall make
reasonable efforts to minimize disruption of the Executive’s other activities. 
The Corporation shall reimburse the Executive for reasonable expenses incurred
in connection with such cooperation.

6.                 
CHANGE IN CORPORATE CONTROL

(a)                
If at any time upon, or during the
period of twenty-four (24) consecutive months following, the occurrence of a
Change in Corporate Control (as defined below), and during the Term of this
Agreement, the Executive is involuntarily terminated (other than for Cause), or
resigns his employment for Good Reason, the Executive shall be entitled to the
following:

(i)                 
Base Compensation accrued through
the date of termination, based on the number of days in such year that had
elapsed as of the termination date;

(ii)               
any accrued but unpaid PTO pay
through the date of termination;

(iii)             
any bonuses earned but unpaid with
respect to fiscal years or other completed bonus periods preceding the
termination date;

(iv)              
any nonforfeitable benefits
payable to the Executive under the terms of any deferred compensation,
incentive or other benefit plans maintained by the Corporation, payable in
accordance with the terms of the applicable plan;

(v)               
any expenses owed to the Executive
under Section 4(d);

 

5

  

 

(vi)              
the pro-rated portion of the
target annual bonus that the Executive would have earned for the year in which
the termination occurs (if he had remained employed for the entire year), based
on the number of days in such year that had elapsed as of the termination date;

(vii)            
all of Executive’s outstanding
stock options, restricted stock or other equity awards with time-based vesting
shall become fully vested and in the case of stock options, exercisable in
full, and the Executive shall have the right to exercise such stock options
during a period of ninety (90) days following the termination of employment,
unless otherwise expressly provided in the applicable award agreement;

(viii)          
all of Executive’s outstanding
stock options, restricted stock, restricted stock units or other equity awards
with performance-based vesting shall become vested based upon a determination
of actual level of achievement of performance goals by the Compensation
Committee of the Board as of immediately prior to the occurrence of the Change
of Corporate Control or as otherwise expressly provided in the applicable award
agreements;

(ix)              
continued coverage pursuant to
Section 601, et seq. of the Employee Retirement Income Security Act of 1974, as
amended (“ERISA”) under any group health plan maintained by the Corporation in
which the Executive participated at the time of his termination at an after-tax
cost to the Executive comparable to the cost that the Executive would have
incurred for the same coverage had he remained employed during such period for
the remainder of the Term of the Agreement or until, if earlier, the date the
Executive obtains comparable coverage under benefit plans maintained by a new
employer or otherwise becomes ineligible to such continued coverage under
ERISA; and

(x)               
a lump sum severance payment equal
to the present value of a series of monthly severance payments for twenty-four
(24) months, each in an amount equal to one-twelfth (1/12th) of the sum of (A)
the Executive’s Base Compensation, as in effect at the time of the Change in
Corporate Control, and (B) the greater of (1) the annual bonus paid to the
Executive for the last fiscal year of the Corporation ending prior to the
Change in Corporate Control or (2) a minimum annual bonus equal to thirty-five
percent (35%) of his Base Compensation.  Such present value shall be calculated
using a discount rate equal to the interest rate on 90-day Treasury bills, as
reported in The Wall Street Journal (or similar publication) on the date of the
Change in Corporate Control.  For purposes of this subsection (x), the amount
of any annual bonus paid for a portion of a fiscal year shall be annualized.

Notwithstanding anything in the
long-term incentive plan, and any other plans, pursuant to which any equity
awards are granted, or any applicable equity award agreements to the contrary,
the payments set forth in subsections (vi), (vii), (viii), (ix) and (x) are
subject to a waiver and general release of claims in favor of the Corporation,
in a form and manner satisfactory to the Corporation, that is executed by the
Executive and which becomes irrevocable within sixty (60) days following the
date of such termination.  All payments to be made or settlements to occur
pursuant to subsections (vii) and (viii) (excluding stock options) shall be
made to the Executive on the first business day following the date that is
sixty (60) days following the date of such termination (except as otherwise
expressly provided in the applicable award agreement).  All payments required
to be made pursuant to subsections (i), (ii), (iii), (v) and (vi) shall be made
within sixty (60) days following the date of such termination and within any
shorter time period required by law.  All payments required to be made pursuant
to subsection (x) shall be made to the Executive on the first business day
following the date that is sixty (60) days following the date of such
termination.  Notwithstanding the foregoing, the severance payment under this
Section shall be payable on a semi-monthly basis instead of a lump sum if the
“Change in Corporate Control” does not constitute a “change in control event”
within the meaning of Treasury Regulation Section 1.409A-3(i)(5) and shall
in any event comply with the provisions of Section 8.

(b)               
For purposes of this Agreement, a
“Change in Corporate Control” shall have the meaning set forth in the
Corporation’s 2016 Long-Term Incentive Plan.

(c)                
Notwithstanding anything else in
this Agreement to the contrary, in the event that it shall be determined that
any payments or distributions by the Corporation to or for the benefit of the
Executive, whether paid or payable or distributed or distributable pursuant to
the terms of this Agreement or otherwise ( together, the “Payments”) would
constitute “parachute payments” within the meaning of Section 280G of the Code,
then the Payments shall be payable either in (i) full or (ii) as to such lesser
amount which would result in no portion of such Payments being subject to the
excise tax imposed under Section 4999 of the Code, such that the Executive
shall receive the greater, on an after-tax basis, of either (i) or (ii) above,
as determined by an independent accountant or tax advisor (“Independent Tax
Advisor”) selected by the Corporation.  In the event that the Payments are to
be reduced pursuant to this Section 6(c), such Payments shall be reduced as
determined by the Independent Tax Advisor such that the reduction of
compensation to be provided to or for the benefit of the Executive as a result
of this Section 6(c) is minimized and to effectuate that, Payments shall be
reduced (i) by first reducing or eliminating the portion of such Payments which
is not payable in cash (other than that portion of such payments that is
subject to clause (iii) below), (ii) then by reducing or eliminating cash
Payments (other than that portion of such 

6

  

 

Payments
subject to clause (iii) below) and (iii) then by reducing or eliminating the
portion of such Payments (whether or not payable in cash) to which Treas. Reg.
§1.280G-1 Q/A 24(c) (or any successor provision thereto) applies, in each case
in reverse order beginning with Payments which are to be paid the farthest in
time from the date of the transaction constituting a change in ownership of the
Corporation within the meaning of Section 280G of the Code.  Any reductions
made pursuant to this Section 6(c) shall be made in a manner consistent with
the requirements of Section 409A and where two economically equivalent amounts
are subject to reduction but payable at different times, such amounts shall be
reduced on a pro rata basis but not below zero.

(d)               
If any dispute arises between the
Corporation (or any successor) and the Executive regarding Executive’s right to
payments under this Section, the Executive shall be entitled to recover his
attorneys’ fees and costs incurred in connection with such dispute if the
Executive is determined to be the prevailing party.  The following additional
terms and conditions shall apply to the reimbursement of any attorneys fees and
costs: (i) the attorneys fees and costs must be incurred by the Executive
within five years following the date of the Executive’s termination or
resignation; (ii) the attorneys fees and costs shall be paid by the Corporation
by the end of the taxable year following the year in which the attorneys fees
and costs were incurred; (iii) the amount of any attorneys fees and costs paid
by the Corporation in one taxable year shall not affect the amount of any
attorneys fees and costs to be paid by the Corporation in any other taxable
year; and (iv) the Executive’s right to receive attorneys fees and costs may
not be liquidated or exchanged for any other benefit.

7.                 
DEATH 

If the Executive dies during the
Term of this Agreement, the Corporation shall pay to the Executive’s estate the
following:

(i)                 
Base Compensation accrued through
the date of death, based on the number of days in such year that had elapsed as
of the date of death;

(ii)               
any accrued but unpaid PTO through
the date of death;

(iii)             
any bonuses earned but unpaid with
respect to fiscal years or other completed bonus periods preceding the date of
death;

(iv)              
any nonforfeitable benefits
payable to the Executive under the terms of any deferred compensation,
incentive or other benefit plans maintained by the Corporation, payable in
accordance with the terms of the applicable plan;

(v)               
any expenses owed to the Executive
under Sections 4(d);

(vi)              
any pro-rated portion of the
annual bonus that the Executive would have earned for the year in which the
death occurs (if he had remained employed for the entire year), based on the
number of days in such year that had elapsed as of the date of death), payable
at the time that the Corporation pays bonuses to its executive officers for
such year; and 

(vii)            
the treatment of all of
Executive’s outstanding stock options, restricted stock, restricted stock units
or other equity awards (whether subject to time-based vesting or
performance-based vesting) shall be determined in accordance with the long-term
incentive plan, and any other plans, pursuant to which such awards were granted
and the applicable award agreement.

All payments required to be made
pursuant to subsections (i), (ii), (iii) and (v) shall be made to the estate
within sixty (60) days following the date of death and within any shorter time
period required by law.  All payments to be made pursuant to subsection (vii)
(excluding stock options) shall be made to the Executive on the first business
day following the date that is sixty (60) days following the date of such
termination (except as otherwise expressly provided in the applicable award
agreement).  The pro-rated bonus shall be paid in accordance with the
provisions of Section 3(b) after the Compensation Committee has approved
bonuses payable for the year.

8.                 
WITHHOLDING AND SECTION 409A
COMPLIANCE

(a)                
The Corporation shall, to the
fullest extent not prohibited by law, have the right to withhold and deduct
from any payment hereunder any federal, state or local taxes of any kind
required by law to be withheld with respect to any such payment.

(b)               
This Agreement is intended to
comply with the requirements of Section 409A of the Code or an exemption
thereunder, and shall be interpreted and construed consistently with such
intent.  The payments to the Executive pursuant to this Agreement are intended
to be exempt from Section 409A of the Code to the maximum extent possible,
under the separation pay exemption, as short-

7

  

 

term
deferrals, or otherwise.  For purposes of Section 409A of the Code, each
installment payment provided under this Agreement shall be treated as a
separate payment.  In the event the terms of this Agreement would subject the
Executive to additional income taxes, interest or penalties under Section 409A
of the Code (“409A Penalties”), the Corporation and the Executive shall
cooperate diligently to amend the terms of the Agreement to avoid such 409A
Penalties, to the extent possible.  To the extent any amounts under this
Agreement are payable by reference to Executive’s “termination,” “termination
of employment,” or similar phrases, such term shall be deemed to refer to the
Executive’s “separation from service” (as defined in Section 409A of the
Code).  Notwithstanding any other provision in this Agreement, including but
not limited to Sections 5 and 6, if the Executive is a “specified employee” (as
defined in Section 409A(a)(2)(b)(i)), then to the extent any amount payable under
this Agreement (i) constitutes the payment of nonqualified deferred
compensation, within the meaning of Section 409A of the Code, (ii) is payable
upon the Executive’s separation from service, and (iii) under the terms of this
Agreement would be payable prior to the six-month anniversary of the
Executive’s separation from service, such payment shall be delayed and paid to
the Executive, on the first day of the first calendar month beginning at least
six months following the date of termination, or, if earlier, within ninety
(90) days following the Executive’s death to the Executive’s surviving spouse
(or such other beneficiary as the Executive may designate in writing).  Any
reimbursement or advancement payable to the Executive pursuant to this Agreement
shall be conditioned on the submission by the Executive of all expense reports
reasonably required by the Corporation under any applicable expense
reimbursement policy, and shall be paid to the Executive within thirty (30)
days following receipt of such expense reports, but in no event later than the
last day of the calendar year following the calendar year in which the
Executive incurred the reimbursable expense.  Any amount of expenses eligible
for reimbursement, or in-kind benefit provided, during a calendar year shall
not affect the amount of expenses eligible for reimbursement, or in-kind
benefit to be provided, during any other calendar year.  The right to any
reimbursement or in-kind benefit pursuant to this Agreement shall not be
subject to liquidation or exchange for any other benefit.

9.                 
PROTECTION OF CONFIDENTIAL
INFORMATION

The Executive hereby agrees
that, during his employment with the Corporation and thereafter, he shall not,
directly or indirectly, disclose or make available to any person, firm, corporation,
association or other entity for any reason or purpose whatsoever, any
Confidential Information (defined below).  The Executive further agrees that,
upon the date of the Executive’s termination, all Confidential Information in
his possession that is in written or other tangible form shall be returned to
the Corporation and shall not be retained by the Executive or furnished to any
third party, in any form except as provided herein.

Notwithstanding the foregoing,
this Section 9 shall not apply to Confidential Information that (i) was
publicly known at the time of disclosure to the Executive, (ii) becomes
publicly known or available thereafter other than by any means in violation of
this Agreement or any other duty owed to the Corporation by the Executive,
(iii) is lawfully disclosed to the Executive by a third party, or (iv) is
required to be disclosed by law or by any court, arbitrator or administrative
or legislative body with actual or apparent jurisdiction to order the Executive
to disclose or make accessible any information.  As used in this Agreement,
Confidential Information means, without limitation, any non-public confidential
or proprietary information disclosed to Executive or known by the Executive as
a consequence of or through the Executive’s relationship with the Corporation,
in any form, including electronic media.  Confidential Information also
includes, but is not limited to, the Corporation’s business plans and financial
information, marketing plans, and business opportunities.  Nothing herein shall
limit in any way any obligation the Executive may have relating to Confidential
Information under any other agreement or promise to the Corporation.

The Executive specifically
acknowledges that all such Confidential Information, whether reduced to
writing, maintained on any form of electronic media, or maintained in the mind
or memory of the Executive and whether compiled by the Corporation, and/or the
Executive, derives independent economic value from not being readily known to
or ascertainable by proper means by others who can obtain economic value from
its disclosure or use, that reasonable efforts have been made by the
Corporation to maintain the secrecy of such information, that such information
is the sole property of the Corporation and that any retention and use of such
information by the Executive during his employment with the Corporation (except
in the course of performing his duties and obligations to the Corporation) or
after the termination of his employment shall constitute a misappropriation of
the Corporation’s trade secrets.

The Executive agrees that
Confidential Information gained by the Executive during the Executive’s
association with the Corporation, has been developed by the Corporation through
substantial expenditures of time, effort and money and constitute valuable and
unique property of the Corporation.  The Executive recognizes that because his
work for the Corporation will bring him into contact with confidential and
proprietary information of the Corporation, the restrictions of this Section 9
are required for the reasonable protection of the Corporation and its
investments and for the Corporation’s reliance on and confidence in the
Executive.  The Executive further understands and agrees that the foregoing
makes it necessary for the protection of the Corporation’s business that the
Executive not compete with the Corporation during his employment with the
Corporation and not compete with the Corporation for a reasonable period
thereafter, as further provided in the following Section.

8

  

 

The
Executive understands that nothing contained in this Agreement limits
Executive’s ability to file a charge or complaint with the Equal Employment
Opportunity Commission, the National Labor Relations Board, the Occupational
Safety and Health Administration, the Securities and Exchange Commission or any
other federal, state or local governmental agency or commission (each a
“Government Agency”).  Executive further understands that this Agreement does
not limit Executive’s ability to communicate with any Government Agency or
otherwise participate in any investigation or proceeding that may be conducted
by any Government Agency, including providing documents or other information,
without notice to the Company.  However, to the maximum extent permitted by
law, the Executive agrees that if such a charge or complaint is made, the
Executive shall not be entitled to recover any individual monetary relief or
other individual remedies.  This Agreement does not limit or prohibit
Executive’s right to receive an award for information provided to any
Government Agency to the extent that such limitation or prohibition is a
violation of law.

The Executive affirms that the
Executive has not divulged any proprietary or confidential information of the
Corporation and will continue to maintain the confidentiality of such
information consistent with the Corporation’s policies and the Executive’s
agreement(s) with the Corporation and/or common law.  The Executive further
affirms that the Executive is not aware of and has not reported any allegations
of wrongdoing by the Corporation or its officers or directors, including any
allegations of corporate fraud, to a Government Agency or other person, and
therefore has not been retaliated against for reporting any allegations of
wrongdoing by the Corporation or its officers or directors, including any
allegations of corporate fraud.

10.             
COVENANT NOT TO COMPETE

The Executive hereby agrees that
he will not, either during the Term or at all times until one year from the
time his employment ceases, or, if later, during any period in which he is
receiving any severance or change in control payments under Sections 5(a) or 6
(the “Restricted Period”), engage in the (i) ownership or operation of Health
Care Facilities (defined below); (ii) investment in or lending to Health Care
Facilities; (iii) management of Health Care Facilities; or (iv) provision of
any planning, development or executive services for Health Care Facilities. 
“Health Care Facilities” means any senior housing facilities, facilities used
or intended for the delivery of health care services, active adult communities,
independent living facilities, assisted living facilities, skilled nursing
facilities, inpatient rehabilitation facilities, ambulatory surgery centers,
medical office buildings and/or hospitals.  The Executive will be deemed to be
engaged in such competitive business activities if he participates in such a
business enterprise as an employee, officer, director, consultant, agent,
partner, proprietor, or other participant; provided that the ownership of no
more than two percent (2%) of the stock of a publicly traded corporation
engaged in a competitive business shall not be deemed to be engaging in
competitive business activities.

During the Restricted Period,
Executive will be prohibited, to the fullest extent allowed by applicable law,
from directly or indirectly, individually or on behalf of any person or entity,
encouraging, inducing, attempting to induce, recruiting, attempting to recruit,
soliciting or attempting to solicit or participating in the recruitment for
employment, contractor or consulting opportunities anyone who is employed at
that time by the Corporation or any subsidiary or affiliate.

During his employment with the
Corporation and thereafter, Executive will not make or authorize anyone else to
make on Executive’s behalf any disparaging or untruthful remarks or statements,
whether oral or written, about the Corporation, its operations or its products,
services, affiliates, officers, directors, employees, or agents, or issue any
communication that reflects adversely on or encourages any adverse action
against the Corporation.  Executive will not make any direct or indirect
written or oral statements to the press, television, radio or other media or
other external persons or entities concerning any matters pertaining to the
business and affairs of the Corporation, its affiliates or any of its officers
or directors.

While employed by the
Corporation and during the Restricted Period, the Executive will communicate
the contents of this Section 10 to any person, firm, association, partnership,
corporation or other entity that the Executive intends to be employed by,
associated with, or represent.

11.             
INJUNCTIVE RELIEF

The Executive acknowledges and
agrees that it would be difficult to fully compensate the Corporation for
damages resulting from the breach or threatened breach of the covenants set
forth in Sections 9 and 10 of this Agreement and accordingly agrees that the
Corporation shall be entitled to temporary and injunctive relief, including
temporary restraining orders, preliminary injunctions and permanent
injunctions, without the need to post any bond, to enforce such provisions in
any action or proceeding instituted in the United States District Court for the
Northern District of Ohio or in any court in the State of Ohio having subject
matter jurisdiction.  This provision with respect to injunctive relief shall
not, however, diminish the Corporation’s right to claim and recover damages.

 

9

  

 

12.             
NOTICES 

All notices or communications
hereunder shall be in writing and sent by overnight courier, certified mail, or
registered mail, (return receipt requested), postage prepaid, addressed as
follows (or to such other address as such party may designate in writing from
time to time):

If to the Corporation:

Welltower Inc.

4500 Dorr Street

Toledo, OH 43615

Attention:  General Counsel

If to the Executive, at the
address on file with the Corporation’s Human Resources department.

The actual date of mailing, as
shown by a mailing receipt therefor, shall determine the time at which notice
was given.

13.             
SEPARABILITY 

If any provision of this
Agreement shall be declared to be invalid or unenforceable, in whole or in
part, such invalidity or unenforceability shall not affect the remaining
provisions hereof which shall remain in full force and effect.

It is expressly understood and
agreed that although the parties consider the restrictions contained in this
Agreement to be reasonable, if a court determines that the time or territory or
any other restriction contained in this Agreement is an unenforceable
restriction on the activities of the Executive, no such provision of this
Agreement shall be rendered void but shall be deemed amended to apply as to
such maximum time and territory and to such extent as such court may judicially
determine or indicate to be reasonable.

14.             
ASSIGNMENT 

This Agreement shall be binding
upon and inure to the benefit of the heirs and representatives of the Executive
and the assigns and successors of the Corporation, but neither this Agreement
nor any rights or obligations hereunder shall be assignable or otherwise
subject to hypothecation by the Executive.

15.             
ENTIRE AGREEMENT

This Agreement represents the
entire agreement of the parties and shall supersede any and all previous
contracts, arrangements or understandings between the Corporation and the
Executive (including the Prior Employment Agreement).  The Agreement may be
amended at any time by mutual written agreement of the parties hereto.

16.             
GOVERNING LAW AND ARBITRATION

This Agreement shall be
construed, interpreted, and governed in accordance with the laws of the State
of Ohio, without regard to principles of conflicts of laws.

Any dispute, controversy or
claim arising out of or related to this Agreement or any breach of this
Agreement shall be submitted to and decided by binding arbitration. 
Arbitration shall be administered exclusively by the American Arbitration
Association and shall be conducted in accordance with the National Rules for
the Resolution of Employment Disputes.  Any arbitral award determination shall
be final and binding upon the parties.  Judgment may be entered in any court
having jurisdiction.  Notwithstanding the foregoing, the Corporation shall be
entitled to seek a restraining order or injunction in any court of competent
jurisdiction to prevent any continuation of any violation of Sections 9 or 10
hereof.

17.             
SURVIVAL 

Subject to any limits on
applicability contained therein, Sections 9 through 11 and Section 16 hereof
shall survive and continue in full force in accordance with their terms
notwithstanding any termination of the Term or this Agreement.

10

  

 

[Remainder
of Page Intentionally Left Blank] 

 

11

  

 

IN WITNESS WHEREOF, the Corporation has caused this
Agreement to be duly executed, and the Executive has hereunto set his hand, as
of the day and year first above written.

 

WELLTOWER INC., a
Delaware corporation

 

By:           /s/ Matthew McQueen                                                

Name:      Matthew McQueen

Title:         Senior Vice President, General Counsel
and Secretary

 

 

SCOTT A. ESTES, Executive

 

By:           /s/ Scott A. Estes                                                          

12

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00273-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00273-of-00352.parquet"}]]